<DOC>
	<DOCNO>NCT01409915</DOCNO>
	<brief_summary>A medicine FDA-approved bone marrow stimulation ( call Leukine ) test ability tolerate Alzheimer 's disease patient potentially improve memory .</brief_summary>
	<brief_title>Study Safety &amp; Efficacy Leukine® Treatment Alzheimer 's Disease</brief_title>
	<detailed_description>Preliminary preclinical result demonstrate GM-CSF ( Granulocyte macrophage colony-stimulating factor , e.g . Leukine®/Sargramostim ) rapidly reduce cerebral amyloid deposition completely reverse memory deficit transgenic mouse model Alzheimer 's Disease ( AD ) . To assess efficacy GM-CSF human , investigator perform retrospective analysis cognition study human patient undergo hematopoietic cell transplantation cancer garner cognitive impairment chemotherapy irradiation . In patient receive colony-stimulating factor ( CSF ) stimulate bone marrow recover immune system function , investigator find receive GM-CSF ( Leukine®/Sargramostim ) plus G-CSF ( Filigrastim ) significantly improve cognitive function compare receive G-CSF alone . These finding combine two decade accrue safety data use recombinant human GM-CSF , Leukine®/Sargramostim , elderly leukopenic patient , suggest Leukine® test treatment reverse cerebral amyloid pathology cognitive impairment AD .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>1. age 55 85 year ; 2. mildtomoderate Alzheimer 's Disease diagnosis ( MiniMental State Examination 1026 inclusive ) ; 3. antidementia treatment stable treatment least 2 month ( i.e . cholinesterase inhibitor and/or Memantine Axona ) ; 4. stable medication least 30 day prior screen ; 5. fluent English ; 6. physically able participate medical history , clinical exam test ; 7. study partner accompany schedule visit . 1. clinically relevant arrhythmia ; 2. rest pulse less 50 ; 3. active cancer nonmelanoma skin cancer ; 4. use another investigatory drug within 2 month screen ; 5. significant stroke head trauma history MRI ; 6. contraindication MRI ; 7. diagnostic Statistical Manual Mental DisordersIV criterion current major psychiatric disorder ; 8. sensitivity yeast yeast product ; 9. impair kidney function measure Glomerular Filtration Rate le 60 milliliters/min ; 10. preexist fluid retention , pulmonary infiltrates , congestive heart failure ; 11. history moderatetosevere lung disease ; 12. history moderatetosevere liver disease ; 13. pregnant woman , woman feel likely become pregnant study ; 14. prisoner .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Alzheimer 's disease</keyword>
	<keyword>neuropsychological assessment</keyword>
	<keyword>Granulocyte-Macrophage Colony-Stimulating Factor</keyword>
	<keyword>Leukine</keyword>
</DOC>